1
|
Jeong D, Joo SW, Shinde VV, Cho E, Jung S. Carbohydrate-Based Host-Guest Complexation of Hydrophobic Antibiotics for the Enhancement of Antibacterial Activity. Molecules 2017; 22:E1311. [PMID: 28786953 PMCID: PMC6152325 DOI: 10.3390/molecules22081311] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Accepted: 08/05/2017] [Indexed: 01/29/2023] Open
Abstract
Host-guest complexation with various hydrophobic drugs has been used to enhance the solubility, permeability, and stability of guest drugs. Physical changes in hydrophobic drugs by complexation have been related to corresponding increases in the bioavailability of these drugs. Carbohydrates, including various derivatives of cyclodextrins, cyclosophoraoses, and some linear oligosaccharides, are generally used as host complexation agents in drug delivery systems. Many antibiotics with low bioavailability have some limitations to their clinical use due to their intrinsically poor aqueous solubility. Bioavailability enhancement is therefore an important step to achieve the desired concentration of antibiotics in the treatment of bacterial infections. Antibiotics encapsulated in a complexation-based drug delivery system will display improved antibacterial activity making it possible to reduce dosages and overcome the serious global problem of antibiotic resistance. Here, we review the present research trends in carbohydrate-based host-guest complexation of various hydrophobic antibiotics as an efficient delivery system to improve solubility, permeability, stability, and controlled release.
Collapse
Affiliation(s)
- Daham Jeong
- Department of Bioscience and Biotechnology, Microbial Carbohydrate Resource Bank (MCRB), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea.
| | - Sang-Woo Joo
- Department of Bioscience and Biotechnology, Microbial Carbohydrate Resource Bank (MCRB), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea.
| | - Vijay Vilas Shinde
- Department of Bioscience and Biotechnology, Microbial Carbohydrate Resource Bank (MCRB), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea.
| | - Eunae Cho
- Department of Bioscience and Biotechnology, Microbial Carbohydrate Resource Bank (MCRB), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea.
| | - Seunho Jung
- Department of Bioscience and Biotechnology, Microbial Carbohydrate Resource Bank (MCRB), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea.
- Center for Biotechnology Research in UBITA (CBRU), Institute for Ubiquitous Information Technology and Applications (UBITA), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea.
| |
Collapse
|
2
|
Taha M, Chai F, Blanchemain N, Neut C, Goube M, Maton M, Martel B, Hildebrand HF. Evaluation of sorption capacity of antibiotics and antibacterial properties of a cyclodextrin-polymer functionalized hydroxyapatite-coated titanium hip prosthesis. Int J Pharm 2014; 477:380-9. [PMID: 25455780 DOI: 10.1016/j.ijpharm.2014.10.026] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2014] [Revised: 10/09/2014] [Accepted: 10/11/2014] [Indexed: 11/26/2022]
Abstract
Infection still present as one of common complications after total hip replacement (∼2.5%), which may cause serious outcomes. For preventing such risk, loading antibiotics onto implants for increasing local drug concentration at targeted sites could be a solution. This study aims at modifying the surface of hydroxyapatite (HA) coated titanium hip implant material (Ti-HA) with polymer of cyclodextrin (polyCD) for loading antibiotics, to achieve a sustained local drug delivery. Two widely applied antibiotics (tobramycin and rifampicin) in orthopedic surgery were loaded alone or in combination. The drug adsorption isotherm, drug release kinetics and drug's efficacy were thoroughly investigated. The results proved that polyCD coating significantly improved the affinity of both drugs to Ti-HA surface, while the mechanism of drug-polyCD interaction varies from the nature of drug, courtesy of the structural complex of polyCD. The advantage of dual-drug loading was highlighted by its strong efficacy against both Staphylococcus aureus and Enterobacter cloacae, which overcomes the limitation of mono-drug loading for an effective treatment against both bacterial strains. The prolonged antibacterial activity of antibiotic loaded Ti-HA-polyCD samples confirmed that polyCD could be a promising drug-delivery system, for sustained antibiotics release or other potential applications e.g., antimitotic agent release.
Collapse
Affiliation(s)
- Mariam Taha
- Université Lille Nord De France, 59000 Lille, France; INSERM U1008, Controlled Drug Delivery System and Biomaterials, University Lille 2, F-59006 Lille, France
| | - Feng Chai
- Université Lille Nord De France, 59000 Lille, France; INSERM U1008, Controlled Drug Delivery System and Biomaterials, University Lille 2, F-59006 Lille, France
| | - Nicolas Blanchemain
- Université Lille Nord De France, 59000 Lille, France; INSERM U1008, Controlled Drug Delivery System and Biomaterials, University Lille 2, F-59006 Lille, France.
| | - Christel Neut
- Université Lille Nord De France, 59000 Lille, France; INSERM U995, Laboratoire de Bactériologie, University Lille 2, 59006 Lille, France
| | - Michel Goube
- BJR-France, R&D Department, 1 Bis rue Saint Roch, 62170 Bréxent-Énocq, France
| | - Mickael Maton
- Université Lille Nord De France, 59000 Lille, France; INSERM U1008, Controlled Drug Delivery System and Biomaterials, University Lille 2, F-59006 Lille, France
| | - Bernard Martel
- Université Lille Nord De France, 59000 Lille, France; UMET - Ingénierie des Systèmes Polymères, University Lille 1, 59655 Villeneuve d'Ascq, France
| | - Hartmut F Hildebrand
- Université Lille Nord De France, 59000 Lille, France; INSERM U1008, Controlled Drug Delivery System and Biomaterials, University Lille 2, F-59006 Lille, France
| |
Collapse
|